Amgen
NEUPOGEN
Manufacturer:
Amgen
Name:
NEUPOGEN
HCPCS Code Descriptor:
Injection, filgrastim (g-csf), excludes biosimilars, 1 microgram
Category:
J Code
HCPCS:
J1442
NDC(s):
55513-0924-91, 55513-0924-10, 55513-0924-01, 55513-0530-01, 55513-0530-10, 55513-0546-01, 55513-0546-10, 55513-0209-91, 55513-0209-01, 55513-0209-10
Primary Type:
Oncology Colony Stimulating Factor
Generic Status:
Single-Source
Route of Administration:
Injection
About:
NEUPOGEN is an Oncology Colony Stimulating Factor drug manufactured by Amgen and administered via the Injection route of administration. The J Code: J1442 is aligned to the drug NEUPOGEN.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/14
HCPCS Effective Date:
1/1/16
HCPCS Short Description:
Inj filgrastim excl biosimil
Billing and Coding Guide:
https://www.amgensupportplus.com/-/media/Themes/Amgen/amgensupportplus-com/Amgensupportplus-com/documents/amgensupportplus/Neulasta-Neupogen-Physician-Billing-and-Coding-Guide.pdf
Patient Assistance:
http://www.amgensafetynetfoundation.com
https://www.amgenassist.com/copay